Proper education on semaglutide injection sites can make your experience easier and more effective, helping you achieve your health goals with confidence
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight (NCT04881760)
Researchers are eager to explore further and patients may one day benefit from its innovative approach to appetite regulation, energy balance and glucose metabolism
Patients who have started GLP-1 therapy in Sacramento report transformative results
There are currently no Therapeutic Goods Administration-approved incretin-based medicines available on the Pharmaceutical Benefits Scheme (PBS) for obesity management (Table 7)
Published studies have demonstrated accelerated wound healing in skin, hair follicles, gastrointestinal tract, bone tissue, and nerve tissue across multiple animal models